Hemostemix Inc.
HEM.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.76M | 1.70M | 2.15M | 2.71M | 1.93M |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.74M | 3.68M | 3.94M | 3.01M | 1.93M |
| Operating Income | -3.74M | -3.68M | -3.94M | -3.01M | -1.93M |
| Income Before Tax | -3.26M | -2.98M | -3.30M | -2.36M | -2.22M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.26 | -2.98 | -3.30 | -2.36 | -2.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.26M | -2.98M | -3.30M | -2.36M | -2.22M |
| EBIT | -3.74M | -3.68M | -3.94M | -3.01M | -1.93M |
| EBITDA | -3.74M | -3.68M | -3.94M | -3.01M | -1.93M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 732.70M | 674.18M | 605.80M | 506.87M | 447.52M |
| Average Diluted Shares Outstanding | 732.70M | 674.18M | 605.80M | 506.87M | 447.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |